CVRdatabase
Menu

Chr. Olesen Pharmaceuticals A/S

Public limited companyCVR 32090168GentofteActive

Chr. Olesen Pharmaceuticals A/S is a public limited company, based in Gentofte, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2009. Net profit rose 237% from 2024 to 2025, ending at DKK 237k.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 1.2m+32.2% vs. 2024
Net profitDKK 237k+236.5% vs. 2024
EquityDKK 1.7m+8.6% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 32% (2024 → 2025), to DKK 1.2m.
  • Net profit rose 237% (2024 → 2025), to DKK 237k.
  • Equity rose 9% (2024 → 2025), to DKK 1.7m.

Management and owners, last 24 months

  • New in management: Mads Christian Olesen (director, 26/01/2026), Christian Dam Olesen (board member, 26/01/2026) and Christian Dam Olesen (ceo, 26/01/2026) (+1).
  • Stepped down: Mads Christian Olesen (board member, 26/01/2026), Mads Christian Olesen (ceo, 25/01/2026) and Hans Schröder-von Volkmann (board member, 26/01/2026) (+1).
  • New owners registered: Svvf Ug & Co. KG (25/11/2024).
  • No longer registered as owner: Tobias Facklam (25/11/2024) and Hans Schröder-von Volkmann (25/11/2024).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2mDKK 1.4mDKK 1.6mDKK 1.8m202020212022202320242025
EquityNet profit
Financial figures for Chr. Olesen Pharmaceuticals A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit1,0267401,2151,3839161,211+32.2%
Operating profit (EBIT)679406740851377581+53.9%
Profit before tax584322597542104306+195.2%
Net profit45525146542171237+236.5%
Total assets9,41412,95814,98614,06510,83611,360+4.8%
Equity5998501,3161,7371,6071,745+8.6%
Liabilities8,81412,10813,67012,3289,2299,615+4.2%
Cash and cash equivalents02921832060−100%
Average number of employees11––330%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Chr. Olesen Pharmaceuticals A/S
Financial yearPeriodPublishedFigures forDocuments
202501/10/2024 – 30/09/202513/02/2026The companyPDF not statedXBRL
202401/10/2023 – 30/09/202428/02/2025The companyPDFXBRL
202301/10/2022 – 30/09/202301/03/2024The companyPDFXBRL
202201/10/2021 – 30/09/202201/03/2023The companyPDFXBRL
202101/10/2020 – 30/09/202101/03/2022The companyPDFXBRL
202001/10/2019 – 30/09/202012/02/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0112209/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 1.2mNo. 202 of 232
Better than 13% of the companies in the industry
EquityDKK 1.7mNo. 176 of 232
Better than 24% of the companies in the industry
Number of employees2No. 158 of 232
Better than 32% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 41,207of 69,742
Better than 41%
No. 26,138of 69,964
Better than 63%
Same industry and fewer than 20 employees150 companies in the comparison
No. 120of 150
Better than 20%
No. 95of 150
Better than 37%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 18,168of 24,791
Better than 27%
No. 15,338of 24,909
Better than 38%
All companies of type A/S18,025 companies in the comparison
No. 15,450of 17,786
Better than 13%
No. 14,863of 18,024
Better than 18%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Chr. Olesen Pharmaceuticals A/SDKK 1.2m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Chr. Olesen Pharmaceuticals A/SDKK 237k
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Chr. Olesen Pharmaceuticals A/SDKK 1.7m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Chr. Olesen Pharmaceuticals A/S2
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Chr. Olesen Pharmaceuticals A/S

Management

6 active registrations

Executive management

Executive management at Chr. Olesen Pharmaceuticals A/S
NameRoleAppointed
Phillip Christian Dam Quitzau OlesenDirector15/03/2023
Mads Christian OlesenDirector26/01/2026
Christian Dam OlesenCEO26/01/2026

Board of directors

Board of directors at Chr. Olesen Pharmaceuticals A/S
NameRoleAppointed
Tobias FacklamChair of the board22/12/2016
Christian Dam OlesenBoard member26/01/2026
Fabian von VolkmannBoard member26/01/2026
Founders
Chrisjopali ApS, Chr. Olesen A/S
Former management (12)
Former management at Chr. Olesen Pharmaceuticals A/S
NameRoleAppointedResigned
Svend Aage JohansenBoard member31/03/200922/12/2016
Jens Havskov ThorsenBoard member31/03/200920/01/2011
Terje AarboghBoard member01/05/201217/12/2013
Terje AarboghCEO01/05/201217/12/2013
Svend Aage JohansenCEO17/12/201323/05/2014
Allan ArdensøBoard member17/12/201323/05/2014
Mads Christian OlesenBoard member23/05/201426/01/2026
Mads Christian OlesenCEO23/05/201425/01/2026
Hans-Hermann WillChair of the board30/09/201401/03/2015
Jens H ThorsenChair of the board01/03/201522/12/2016
Hans Schröder-von VolkmannBoard member22/12/201626/01/2026
Christian Dam OlesenDirector08/11/202225/01/2026

Signing rule: Selskabet tegnes af et medlem af direktionen, et medlem af bestyrelsen eller af den samlede bestyrelse.

Address and production units

1 active production units

Jægersborg Alle 164
2820 Gentofte

Gentofte Municipality · Postcode 2820

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
CHR. OLESEN PHARMACEUTICALS A/SJægersborg Alle 164, 2820 Gentofte21015183159

Purpose

Selskabets formål er at drive virksomhed ved handel og distribution af aktive farmaceutiske stoffer til human brug.

The purpose is quoted from the register in Danish.

Changes year by year

50 registered events
20269 changesaccounts 1 · management 8
  • Annual report for 2025 published
  • Fabian von Volkmann appointed board member
  • Christian Dam Olesen appointed ceo
  • Christian Dam Olesen appointed board member
  • Mads Christian Olesen appointed director
  • Hans Schröder-von Volkmann stepped down as board member
  • Mads Christian Olesen stepped down as board member
  • Christian Dam Olesen stepped down as director
  • Mads Christian Olesen stepped down as ceo
20251 changeaccounts 1
  • Annual report for 2024 published
20244 changesownership 3 · accounts 1
  • SVVF UG & Co. KG registered as owner (50%)
  • Tobias Facklam is no longer registered as owner
  • Hans Schröder-von Volkmann is no longer registered as owner
  • Annual report for 2023 published
20232 changesmanagement 1 · accounts 1
  • Phillip Christian Dam Quitzau Olesen appointed director
  • Annual report for 2022 published
20222 changesmanagement 1 · accounts 1
  • Christian Dam Olesen appointed director
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20166 changesmanagement 4 · ownership 2
  • Tobias Facklam appointed chair of the board
  • Hans Schröder-von Volkmann appointed board member
  • Jens H Thorsen stepped down as chair of the board
  • Svend Aage Johansen stepped down as board member
  • Tobias Facklam registered as owner (25%)
  • Hans Schröder-von Volkmann registered as owner (25%)
20156 changesownership 4 · management 2
  • CHR. OLESEN A/S registered as owner (50%)
  • CHR. OLESEN A/S is no longer registered as owner
  • CHRISJOPALI ApS is no longer registered as owner
  • Jens H Thorsen appointed chair of the board
  • Hans-Hermann Will stepped down as chair of the board
  • CHR. OLESEN A/S registered as owner (90%)
20145 changesmanagement 5
  • Hans-Hermann Will appointed chair of the board
  • Mads Christian Olesen appointed ceo
  • Mads Christian Olesen appointed board member
  • Allan Ardensø stepped down as board member
  • Svend Aage Johansen stepped down as ceo
20135 changesmanagement 4 · ownership 1
  • Allan Ardensø appointed board member
  • Svend Aage Johansen appointed ceo
  • Terje Aarbogh stepped down as board member
  • Terje Aarbogh stepped down as ceo
  • CHRISJOPALI ApS registered as owner (10%)
20123 changesmanagement 2 · capital 1
  • Terje Aarbogh appointed board member
  • Terje Aarbogh appointed ceo
  • Share capital changed from 500,000 DKK to 588,300 DKK
20111 changemanagement 1
  • Jens Havskov Thorsen stepped down as board member
20101 changeaddress 1
  • Moved to Jægersborg Alle 164, 2820 Gentofte
20094 changesindustry 1 · founded 1 · management 2
  • Industry changed to Wholesale of pharmaceutical goods and nursing supplies (464610)
  • Registered as CHR. OLESEN PHARMACEUTICALS A/S
  • Jens Havskov Thorsen appointed board member
  • Svend Aage Johansen appointed board member

Related companies

Same industry in Gentofte

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction